Tuesday, February 27, 2018

New advances in medication for muscle disease in children

Spinraza, the gene therapy medication, also provides significant improvements in cases with the next most severe form of neuromuscular disease, spinal muscular atrophy (SMA), which afflicts children from 6 to 18 months of age.

from Top Health News -- ScienceDaily http://ift.tt/2GM4vIf

No comments:

Post a Comment

This simple blood test might detect depression before symptoms appear

A new study suggests depression may soon be detectable through a simple blood test—by tracking how certain immune cells age. Researchers fou...